Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will position Tilray to respond to significant projected growth in demand for its medical cannabis products in Canada as well as the European Union, Australia, New Zealand and Latin America.

“This is another strategic milestone for Tilray as we aim to build the world’s most trusted and admired medical cannabis brand,” said Brendan Kennedy, Chief Executive Officer of Tilray. “As governments around the world increase access to medical cannabis, and as Canada prepares to legalize and regulate cannabis for responsible adult consumption, this investment will enable us to serve the rapidly expanding global market for quality-controlled, rigorously tested medical cannabis products.”

Expanded Capacity to Accelerate Tilray’s Global Expansion Plans

Tilray was the first licensed producer to legally export medical cannabis products from North America to the European Union, Australia, New Zealand and South America. Currently, Tilray products – including pharmaceutical-grade whole flower, oils, and capsules – are available in 6 countries spanning 4 continents. The company is aggressively expanding international distribution of its products with plans to export to 5 additional countries by the end of 2017.

In 2016, Tilray also became the first medical cannabis licensed producer in North America to be GMP-certified in accordance with the European Medicines Agency’s (EMA) Good Manufacturing Practice (GMP) standards. GMP certification is the most rigorous standard that manufacturers of medical products must meet in their production processes, and it provides regulators and health care providers in countries new to medical cannabis with certainty that Tilray products are a safe and smart choice.

Tilray’s Best-in-Class Production Facilities

Tilray currently owns and operates one of the world’s most sophisticated, federally-licensed medical cannabis cultivation and processing facilities, located in Nanaimo, British Columbia. The flagship $30 million facility, which opened in 2014 and achieved EU GMP certification in 2016, has the capacity to produce 8 metric tonnes of medical cannabis per year. It also houses a state-of-the-art extraction and R&D centre focused on processing raw flower into pharmaceutical-grade products like oils and capsules, in addition to developing new methods of delivery that provide alternatives to smoking.

The company’s second facility being announced today is located in Enniskillen, Ontario on a 100-acre property with 13 acres of existing greenhouse space. The property is currently producing peppers for the Enniskillen Pepper Company. Tilray has submitted an application to Health Canada to receive a federal license to produce medical cannabis on the Enniskillen site. In the first phase of the project, the property will house a 10-acre cannabis greenhouse facility and approximately 40,000 square feet of processing space. The facility marks a total capital investment of up to $30 million and, together with Tilray’s Nanaimo facility, is expected to generate a combined production capacity of as much as 51 metric tonnes by the end of 2018. In future phases to be completed over the next several years, the first 10 acres of Tilray’s new greenhouse in Enniskillen will be expanded up to 30 acres.

Tilray chose Enniskillen because the township is strategically located and has a strong workforce of qualified, skilled agricultural professionals. The Enniskillen facility is expected to hire approximately 50 people to work in operations, production, cultivation and facilities through the end of 2018. Over the next five years, the project is expected to create 200 to 250 full-time jobs in the region.

 

Nanaimo’s Mayor Says Marijuana Industry A Boon To Town’s Economy

CANADA:  The mayor of Nanaimo says his city is rolling in the dough from a new medical marijuana facility opened by Tilray a year ago.

“They are providing jobs out there that are good paying, they’re family incomes. They have hired 95 per cent of their work force [from] local, long-time people,” says Bill McKay.

“It’s just a whole new industry, and there are a lot more of those industries coming, at least we hope so, to Nanaimo.”

McKay says the city has just approved an expansion of the plant, which will let Tilray grow from 50,000 to 250,000 square feet. Currently 115 people are employed at the plant, and Tilray has plans to hire 275 more.

Nanaimo’s Marijuana Trade Diversifies Echronomy

CANADA:  For better or worse, Canada has all its eggs in one oily basket. These days, that’s not going so well. Forecasts suggest that oil jobs are drying up faster than your girlfriend when you fart. Folks, it’s ugly out there. Thankfully, someone somewhere has a plan to make it better. Tilray, a medical marijuana company, is ready to create nearly 300 jobs in Nanaimo, BC.

Tilray already employs 100 people on Vancouver Island, and is looking for workers to grow plants in its new facility. It is also recruiting people to work in various positions, ranging from security to customer service, and even janitorial work. That sounds professional, especially for a stoner company.

At a time when big businesses are closing doors, relatively small businesses like Tilray are opening doors and minds. Perhaps that’s why many believe that the marijuana business could be Canada’s ticket to a more diverse economy that could survive an oil shock. Marijuana is a job creator in the medical field, and will generate far more jobs if legalized for recreational purposes. Canadians can grow it in facilities across the country, and can produce strong, local economies based on a valuable, renewable resource.

Nanaimo-Based Cannabis Producer Partners With UBC On Marijuana Study

CANADA:  Nanaimo based medical cannabis producer Tilray has partnered with the University of British Columbia Okanagan in Canada’s first clinical trial to test marijuana’s effectiveness in treating post-traumatic stress disorder.

The study, still waiting for approval from Health Canada, will be one of the world’s first large-scale clinical trials to evaluate cannabis for treating a mental health disorder.

Existing studies of marijuana’s affect on PTSD have produced anecdotal and observational data, but no information is available from science-based clinical trials. Scientifically generated results could provide physicians with data to make decisions about prescribing cannabis for PTSD patients.

Philippe Lucas, vice-president for patient research and services at Tilray, said a similar study in the U.S. is waiting final approval and funding, but results from both research programs should compliment one anther.

 

Second Medical Marijuana Company Poised For Nanaimo

CANADA:  Two new medical marijuana operations could bookend the Harbour City.

B.C.-based Wildflower Marijuana Inc. is applying to Health Canada to license its two medical marijuana production facilities in the Nanaimo region.

If approved, it says it would become the largest grower and distributor in the country with 150,000 square feet of growing space on either end of the city. This would also be its first grow operation.

According to William MacLean, Wildflower Marijuana chief executive officer, the company looked across Canada for a production site and the Nanaimo area’s temperate and moderate climate is “ideal” for growing the drug. He says the company is aiming to have the lowest carbon footprint in the industry and environment plays a large factor in that.